Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Four Points Innovation has been formed with $130m in funding to nurture Duke drug discovery research, in the latest such move by Deerfield Management.

Caltech-founded ChromaCode has now raised $42.6m in all for its molecular diagnostics technology business.

Ohio State University has signed up to a spinout-focused life sciences venture vehicle run by regional firm Rev1 Ventures that stands at three times the size of its precursor.

Scale Venture Partners has led a $50m funding round for Wanxiang-backed medical data repository provider OM1 that will support product development, sales and marketing.

Velano Vascular has closed a $25m round following an extension that added to $10m provided by investors including Intermountain Healthcare in May.

Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug spinout's latest round to $52.6m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Iqvia has led a $15m series C round for MIT-founded genomic data analytics spinout BC Platforms as part of a strategic partnership agreement.

EPFL's cancer drug developer Cellestia Biotech has extended its funding haul to $48.6m in a series B round that featured existing investor PPF Group.